Clinical trial · Interventional
Cancer End Of Life Evaluation
Evaluation and Validation of Quality Of Life Scales in Palliative Advanced Cancer
NCT01545921CI-TRIAL-00068439CEOLEterminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): End of inclusions without reaching the expected number of patients
Summary
Brief summary (as posted)
The aim of this study is to culturally adapt and to validate Quality Of Life tools dedicated to the end of life for French cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Quality Of Life questionnaires completion | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Arm A
- description
- Patients will complete QoL questionnaires in the following order : MVQOLI, then QLQ-C15-PAL, then QUAL-E, evaluation every month until death
- interventionNames
- Other: Quality Of Life questionnaires completion
- type
- EXPERIMENTAL
- label
- Arm B
- description
- Patients will complete QoL questionnaires in the following order : QLQ-C15-PAL, then MVQOLI, then QUAL-E, evaluation every month until death
- interventionNames
- Other: Quality Of Life questionnaires completion
- type
- EXPERIMENTAL
- label
- Arm C
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Palliative advanced cancer patient (Palliative chemotherapy, analgesic radiotherapy, surgery of comfort accepted). * All cancer locations and cancer type * Patient having the knowledge of their palliative disease stage. * Patient follow-up at least once a month by a palliative caregiver. * Age \> or = 18 years. * Dated and signed consent. * PS \> or = 2 * Life expectation \> or = 1 month. Exclusion Criteria: * Psychiatric Disease or cognitive disorders disrupting the trial understanding and the enlightened and voluntary consent character. * Patient who can not submit itself to the formal follow-up for psychological, social, family or geographical reasons
References
Publications (1)
- DERIVEDPoirier AL, Kwiatkowski F, Commer JM, D'Aillieres B, Berger V, Mercier M, Bonnetain F. Health-related quality of life in cancer patients at the end of life, translation, validation, and longitudinal analysis of specific tools: study protocol for a randomized controlled trial. Trials. 2012 Apr 20;13:39. doi: 10.1186/1745-6215-13-39. PMID 22520742